Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Varenicline tartrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Varenicline 1mg tablets
0410020C0AAABAB
|
Varenicline tartrate | Varenicline tartrate | Central Nervous System | 14,834 |
|
Varenicline 1mg tablets and Varenicline 500microgram tablets
0410020C0AAACAC
|
Varenicline tartrate | Varenicline tartrate | Central Nervous System | 7,677 |
|
Champix 1mg tablets
0410020C0BBABAB
|
Champix | Varenicline tartrate | Central Nervous System | 2,763 |
|
Varenicline 500microgram tablets
0410020C0AAAAAA
|
Varenicline tartrate | Varenicline tartrate | Central Nervous System | 2,038 |
|
Champix 0.5mg/1mg 2 week treatment initiation pack
0410020C0BBACAC
|
Champix | Varenicline tartrate | Central Nervous System | 1,754 |
|
Champix 0.5mg/1mg 4 week treatment initiation pack
0410020C0BBADAC
|
Champix | Varenicline tartrate | Central Nervous System | 744 |
|
Champix 0.5mg tablets
0410020C0BBAAAA
|
Champix | Varenicline tartrate | Central Nervous System | 200 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.